MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PVLA has $263,759K in assets. $31,446K in debts. $206,394K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2887.89%
Quick Ratio
2887.89%
Cash Ratio
2264.33%
Debt to Asset Ratio
11.92%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Prepaid expenses and other curre...
    • Operating lease right-of-use ass...
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty agreement liability
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
206,394 57,982 63,567 70,433
Accounts receivable
-0 0 0
German research and development tax credit receivable
-0 2,216 1,978
Short-term investments
55,459 ---
Prepaid expenses and other current assets
1,378 1,005 1,154 1,336
Total current assets
263,231 58,987 66,937 73,747
Operating lease right-of-use assets, net
528 572 --
Total assets
263,759 59,559 66,937 73,747
Accounts payable
5,443 4,595 3,481 4,557
Derivative liabilities - contingent value right liability
0 2,196 2,216 1,978
Current portion of operating lease liability
209 202 --
Accrued expenses and other current liabilities
3,463 4,351 4,615 3,081
Total current liabilities
9,115 11,344 10,312 9,616
Long-term portion of operating lease liability
375 431 --
Royalty agreement liability
19,799 17,760 16,021 14,511
Derivative liabilities - royalty agreement
2,157 2,041 1,922 1,840
Total liabilities
31,446 31,576 28,255 25,967
Common stock, 0.001 par value 200,000,000 shares authorized 14,313,659 and 12,380,933 shares issued and outstanding at march 31, 2026 and december 31, 2025
14 12 11 11
Additional paid-in capital
383,421 163,338 161,303 159,271
Accumulated other comprehensive (loss) income
95 83 104 -111
Accumulated deficit
-151,217 -135,450 -122,736 -111,391
Total stockholders' equity
232,313 27,983 38,682 47,780
Total liabilities and stockholders' equity
263,759 59,559 66,937 73,747
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$206,394K Short-term investments$55,459K Prepaid expenses andother current assets$1,378K Total current assets$263,231K Operating leaseright-of-use assets, net$528K Total assets$263,759K Total liabilities andstockholders' equity$263,759K Total stockholders'equity$232,313K Total liabilities$31,446K Accumulated deficit-$151,217K Additional paid-in capital$383,421K Royalty agreementliability$19,799K Total currentliabilities$9,115K Derivative liabilities -royalty agreement$2,157K Long-term portion ofoperating lease liability$375K Accumulated othercomprehensive (loss) income$95K Common stock, 0.001 parvalue 200,000,000...$14K Accounts payable$5,443K Accrued expenses andother current...$3,463K Current portion ofoperating lease liability$209K

PALVELLA THERAPEUTICS, INC. (PVLA)

PALVELLA THERAPEUTICS, INC. (PVLA)